Reducing x-ray induced oxidative damages in fibroblasts with graphene oxide

Nanomaterials

Volumn 4, Issue 2, 2014, Pages 522-534

  Qiao, Yong ^a   Zhang, Peipei ^a   Wang, Chaoming ^a   Ma, Liyuan ^a   Su, Ming ^a  

^a Worcester Polytechnic Institute   (United States)

Author keywords

DNA damage; Graphene oxide; Oxidative; Reactive oxygen species (ROS); X ray

Indexed keywords

EID: 84961638926     PISSN: None     EISSN: 20794991     Source Type: Journal    
DOI: 10.3390/nano4020522     Document Type: Article

References (35)

1. Rydberg, B. Clusters of DNA damage induced by ionizing radiation: Formation of short DNA fragments. II. Experimental detection. Radiat. Res. 1996, 145, 200–209.
2. Teh, B.S.; Woo, S.Y.; Butler, E.B. Intensity modulated radiation therapy (IMRT): A new promising technology in radiation oncology. Oncologist 1999, 4, 433–442.
3. Harrison, L.B.; Chadha, M.; Hill, R.J.; Hu, K.; Shasha, D. Impact of tumor hypoxia and anemia on radiation therapy outcomes. Oncologist 2002, 7, 492–508.
4. Lawrence, T.S. Radiation sensitizers and targeted therapies. Oncology 2003, 17, 23–28.
5. Elshaikh, M.; Ljungman, M.; Haken, R.T.; Lichter, A.S. Advances in radiation oncology. Annu. Rev. Med. 2006, 57, 19–31.
6. Wardman, P. Chemical radiosensitizers for use in radiotherapy. Clin. Oncol. 2007, 19, 397–417.
7. Ali, H.; van Lier, J.E. Metal complexes as photo-and radiosensitizers. Chem. Rev. 1999, 99, 2379–2450.
8. Bucci, M.K.; Bevan, A.; Roach, M., III. Advances in radiation therapy: Conventional to 3D, to IMRT, to 4D, and beyond. CA Cancer J. Clin. 2005, 55, 117–134.
9. Chandra, A.; Guerrero, T.; Liu, H.; Tucker, S.; Liao, Z.; Wang, X.; Murshed, H.; Bonnen, M.; Crag, A.; Stevens, C.; et al. Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer. Radiother. Oncol. 2005, 77, 247–253.
10. Comporti, M. Three models of free radical-induced cell injury. Chem. Biol. Interact. 1989, 72, 1–56.
11. Cabiscol, E.; Tamarit, J.; Ros, J. Oxidative stress in bacteria and protein damage by reactive oxygen species. Int. Microbiol. 2000, 3, 3–8.
12. Dewey, W.C.; Ling, C.C.; Meyn, R.E. Radiation-induced apoptosis: Relevance to radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 1995, 33, 781–796.
13. Lobo, V.; Patil, A.; Phatak, A.; Chandra, N. Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn. Rev. 2010, 4, 118–126.
14. Fischer, T.W.; Slominski, A.; Zmijewski, M.A.; Reiter, R.J.; Paus, R. Melatonin as a major skin protectant: From free radical scavenging to DNA damage repair. Exp. Dermatol. 2008, 17, 713–730.
15. Milas, L.; Murray, D.; Brock, W.A.; Meyn, R.E. Radioprotectors in tumor radiotherapy: Factors and settings determining therapeutic ratio. Pharmacol. Ther. 1988, 39, 179–187.
16. Hosseinimehr, S.J. Trends in the development of radioprotective agents. Drug Discov. Today 2007, 12, 794–805.
17. Borek, C. Antioxidants and radiation therapy. J. Nutr. 2004, 134, 3207S–3209S.
18. Mark, F.; Becker, U.; Herak, J.N.; Schulte-Frohlinde, D. Radiolysis of DNA in aqueous solution in the presence of a scavenger: A kinetic model based on a nonhomogeneous reaction of OH radicals with DNA molecules of spherical or cylindrical shape. Radiat. Environ. Biophys. 1989, 28, 81–99.
19. Salas, E.C.; Sun, Z.; Luttge, A.; Tour, J.M. Reduction of graphene oxide via bacterial respiration. ACS Nano 2010, 4, 4852–4856.
20. Liu, G.; Shen, H.; Mao, J.; Zhang, L.; Jiang, Z.; Sun, T.; Lan, Q.; Zhang, Z. Transferrin modified graphene oxide for glioma-targeted drug delivery: In vitro and in vivo evaluations. ACS Appl. Mater. Interfaces 2013, 5, 6909–6914.
21. Qin, X.C.; Guo, Z.Y.; Liu, Z.M.; Zhang, W.; Wan, M.M.; Yang, B.W. Folic acid-conjugated graphene oxide for cancer targeted chemo-photothermal therapy. J. Photochem. Photobiol. B 2013, 120, 156–162.
22. Wang, C.; Wu, C.; Zhou, X.; Han, T.; Xin, X.; Wu, J.; Zhang, J.; Guo, S. Enhancing cell nucleus accumulation and DNA cleavage activity of anti-cancer drug via graphene quantum dots. Sci. Rep. 2013, 3, 1–8.
23. Maity, A.R.; Chakraborty, A.; Mondal, A.; Jana, N.R. Carbohydrate coated, folate functionalized colloidal graphene as a nanocarrier for both hydrophobic and hydrophilic drugs. Nanoscale 2014, 6, 2752–2758.
24. Zhang, L.; Xia, J.; Zhao, Q.; Liu, L.; Zhang, Z. Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small 2010, 6, 537–544.
25. Huang, P.; Xu, C.; Lin, J.; Wang, C.; Wang, X.; Zhang, C.; Zhou, X.; Guo, S.; Cui, D. Folic acid-conjugated graphene oxide loaded with photosensitizers for targeting photodynamic therapy. Theranostics 2011, 1, 240–250.
26. Bitner, B.R.; Marcano, D.C.; Berlin, J.M.; Fabian, R.H.; Cherian, L.; Culver, J.C.; Dickinson, M.E.; Robertson, C.S.; Pautler, R.G.; Kent, T.A.; et al. Antioxidant carbon particles improve cerebrovascular dysfunction following traumatic brain injury. ACS Nano 2012, 6, 8007–8014.
27. Marcano, D.C.; Bitner, B.R.; Berlin, J.M.; Jarjour, J.; Lee, J.M.; Jacob, A.; Fabian, R.H.; Kent, T.A.; Tour, J.M. Design of poly(ethylene glycol)-functionalized hydrophilic carbon clusters for targeted therapy of cerebrovascular dysfunction in mild traumatic brain injury. J. Neurotrauma 2013, 30, 789–796.
28. Chang, Y.; Yang, S.T.; Liu, J.H.; Dong, E.; Wang, Y.; Cao, A.; Liu, Y.; Wang, H. In vitro toxicity evaluation of graphene oxide on A549 cells. Toxicol. Lett. 2011, 200, 201–210.
29. Qiao, Y.; An, J.; Ma, L. Single cell array based assay for in vitro genotoxicity study of nanomaterials. Anal. Chem. 2013, 85, 4107–4112.
30. Qiao, Y.; Wang, C.; Su, M.; Ma, L. Single cell DNA damage/repair assay using HaloChip. Anal. Chem. 2012, 84, 1112–1116.
31. Wu, J.; Clingen, P.H.; Spanswick, V.J.; Mellinas-Gomez, M.; Meyer, T.; Puzanov, I.; Jodrell, D.; Hochhauser, D.; Hartley, J.A. Gamma-H2AX foci formation as a pharmacodynamic marker of DNA damage produced by DNA cross-linking agents: Results from 2 phase I clinical trials of SJG-136 (SG2000). Clin. Cancer Res. 2013, 19, 721–730.
32. Redon, C.E.; Dickey, J.S.; Bonner, W.M.; Sedelnikova, O.A. Gamma-H2AX as a biomarker of DNA damage induced by ionizing radiation in human peripheral blood lymphocytes and artificial skin. Adv. Space Res. 2009, 43, 1171–1178.
33. Box, H.C.; Dawidzik, J.B.; Wallace, J.C.; Hauer, C.R.; Stack, R.F.; Rajecki, M.J.; Budzinski, E.E. An overall perspective of X-ray damage to a DNA oligomer mediated by reactive oxygen species. Radiat. Res. 1999, 152, 575–582.
34. Nakano, H.; Shinohara, K. X-ray-induced cell death: Apoptosis and necrosis. Radiat. Res. 1994, 140, 1–9.
35. He, J.; Chen, W.; Jin, L.; Jin, H. Comet assay and cytokinesis-blocked micronucleus test for monitoring the genotoxic effects of X-ray radiation in humans. Chin. Med. J. 2000, 113, 911–914.